The 1,2-Benzisothiazol-3(2H)-one market outlook remains attractive due to its expanding role as a high‑performance preservative in agro‑chemicals and specialty polymers. Competitive intensity is moderate; a handful of legacy manufacturers dominate volume, while niche entrants leverage proprietary synthesis routes to capture premium segments. Over the next five years, the long‑term outlook is positive, with CAGR projected above 6 % as regulatory pressures drive demand for safer, low‑toxicity alternatives. Innovation is concentrated on green synthesis, catalyst optimization, and functionalization that expands application breadth, fostering a modest but growing pipeline of patented processes. Current demand outpaces supply in Europe and North America, creating a slight upward pressure on spot pricing, whereas Asian capacity is expanding rapidly, gradually rebalancing the market. Key risks include tightening environmental regulations, raw‑material price volatility, and potential trade barriers that could disrupt the emerging supply chain. Stakeholders should monitor policy shifts and invest in sustainable R&D to sustain growth and enhance overall profitability.